EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Clinical features of generalized lipodystrophy in Turkey: A cohort analysis

Ilgin Yildirim Simsir iD, Beyhan Tuysuz iD, Mehmet Nuri Ozbek iD, Seher Tanrikulu iD, Merve Celik Guler iD, Asuman Nur Karhan iD, Yasemin Denkboy Ongen iD, Nilay Gunes iD, Utku Erdem Soyaltin iD, Canan Altay iD, Banu Nur iD, Servan Ozalkak iD und 20 weitere

Diabetes, Obesity and Metabolism · 2023-07 · 25 (7) · 1950-1963

DOI: 10.1111/dom.15061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 11.04.2023. Verfasst von Ilgin Yildirim Simsir und 31 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Department of Internal Medicine, Ege University School of Medicine, Izmir, Turkey. Hauptthemen laut MEDLINE: Lipodystrophy, Congenital Generalized, Diabetes Mellitus, Myocardial Infarction, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To describe the Turkish generalized lipodystrophy (GL) cohort with the frequency of each complication and the death rate during the period of the follow‐up.

Methods

This study reports on 72 patients with GL (47 families) registered at different centres in Turkey that cover all regions of the country. The mean ± SD follow‐up was 86 ± 78 months.

Results

The Kaplan–Meier estimate of the median time to diagnosis of diabetes and/or prediabetes was 16 years. Hyperglycaemia was not controlled in 37 of 45 patients (82.2%) with diabetes. Hypertriglyceridaemia developed in 65 patients (90.3%). The Kaplan–Meier estimate of the median time to diagnosis of hypertriglyceridaemia was 14 years. Hypertriglyceridaemia was severe (≥ 500 mg/dl) in 38 patients (52.8%). Seven (9.7%) patients suffered from pancreatitis. The Kaplan–Meier estimate of the median time to diagnosis of hepatic steatosis was 15 years. Liver disease progressed to cirrhosis in nine patients (12.5%). Liver disease was more severe in congenital lipodystrophy type 2 (CGL2). Proteinuric chronic kidney disease (CKD) developed in 32 patients (44.4%) and cardiac disease in 23 patients (31.9%). Kaplan–Meier estimates of the median time to diagnosis of CKD and cardiac disease were 25 and 45 years, respectively. Females appeared to have a more severe metabolic disease, with an earlier onset of metabolic abnormalities. Ten patients died during the follow‐up period. Causes of death were end‐stage renal disease, sepsis (because of recurrent intestinal perforations, coronavirus disease, diabetic foot infection and following coronary artery bypass graft surgery), myocardial infarction, heart failure because of dilated cardiomyopathy, stroke, liver complications and angiosarcoma.

Conclusions

Standard treatment approaches have only a limited impact and do not prevent the development of severe metabolic abnormalities and early onset of organ complications in GL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipodystrophy, Congenital GeneralizedDiabetes MellitusMyocardial InfarctionRenal Insufficiency, ChronicHypertriglyceridemiaLipodystrophyFemaleHumansTurkeyCohort StudiesKaplan-Meier Estimate

Stichwörter der Autor:innen

generalized lipodystrophymetabolic diseasemortalityorgan complications

Autor:innen und Institutionen

  • Division of Endocrinology, Department of Internal Medicine, Ege University School of Medicine, Izmir, Turkey.
  • Department of Genetics, Istanbul Cerrahpasa University, Istanbul, Turkey.
  • Division of Pediatric Endocrinology, Mardin Artuklu University, Mardin, Turkey.
  • Division of Endocrinology, Department of Internal Medicine, Acibadem Hospital, Istanbul, Turkey.
  • Department of Internal Medicine, Dokuz Eylul University School of Medicine, Izmir, Turkey.
  • Division of Pediatric Gastroenterology, Hepatology and Nutrition, Mersin University Faculty of Medicine, Mersin, Turkey.

ORCID-Profile: Ilgin Yildirim Simsir, Beyhan Tuysuz, Mehmet Nuri Ozbek, Seher Tanrikulu, Merve Celik Guler, Asuman Nur Karhan, Yasemin Denkboy Ongen, Nilay Gunes, Utku Erdem Soyaltin, Canan Altay, Banu Nur, Servan Ozalkak, Ozlem Akgun Dogan, Fatma Dursun, Zafer Pekkolay, Mehmet Ali Eren, Yusuf Usta, Secil Ozisik, Basak Ozgen Saydam, Suleyman Cem Adiyaman, Mehmet Cagri Unal, Gokcen Gungor Semiz, Ihsan Turan, Erdal Eren, Hulya Kayserili, Isabelle Jeru, Corinne Vigouroux, Tahir Atik, Huseyin Onay, Samim Ozen, Elif Arioglu Oral, Baris Akinci

Zitieren

APA

Yildirim Simsir, I., Tuysuz, B., Ozbek, M. N., Tanrikulu, S., Celik Guler, M., Karhan, A. N., Denkboy Ongen, Y., Gunes, N., Soyaltin, U. E., Altay, C., Nur, B., Ozalkak, S., Akgun Dogan, O., Dursun, F., Pekkolay, Z., Eren, M. A., Usta, Y., Ozisik, S., Ozgen Saydam, B., …, & Akinci, B. (2023). Clinical features of generalized lipodystrophy in Turkey: A cohort analysis. Diabetes, Obesity and Metabolism, 25(7), 1950-1963. https://doi.org/10.1111/dom.15061

Vancouver

Yildirim Simsir I, Tuysuz B, Ozbek MN, Tanrikulu S, Celik Guler M, Karhan AN, et al. Clinical features of generalized lipodystrophy in Turkey: A cohort analysis. Diabetes, Obesity and Metabolism. 2023;25(7):1950-1963. doi:10.1111/dom.15061

BibTeX
@article{YildirimSimsir2023,
  author = {Yildirim Simsir, Ilgin and Tuysuz, Beyhan and Ozbek, Mehmet Nuri and Tanrikulu, Seher and Celik Guler, Merve and Karhan, Asuman Nur and Denkboy Ongen, Yasemin and Gunes, Nilay and Soyaltin, Utku Erdem and Altay, Canan and Nur, Banu and Ozalkak, Servan and Akgun Dogan, Ozlem and Dursun, Fatma and Pekkolay, Zafer and Eren, Mehmet Ali and Usta, Yusuf and Ozisik, Secil and Ozgen Saydam, Basak and Adiyaman, Suleyman Cem and Unal, Mehmet Cagri and Gungor Semiz, Gokcen and Turan, Ihsan and Eren, Erdal and Kayserili, Hulya and Jeru, Isabelle and Vigouroux, Corinne and Atik, Tahir and Onay, Huseyin and Ozen, Samim and Arioglu Oral, Elif and Akinci, Baris},
  title = {Clinical features of generalized lipodystrophy in Turkey: A cohort analysis},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2023},
  volume = {25},
  number = {7},
  pages = {1950--1963},
  doi = {10.1111/dom.15061}
}
Kostenlos starten →